Prosecution Insights
Last updated: July 17, 2026
Application No. 18/434,368

VAGINAL SPECULUM AND CERVICAL SCREENING KIT

Non-Final OA §102§112
Filed
Feb 06, 2024
Priority
Sep 02, 2011 — CIP of 8460187 +5 more
Examiner
LAWSON, MATTHEW JAMES
Art Unit
3619
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Viospex
OA Round
3 (Non-Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
11m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
812 granted / 1102 resolved
+21.7% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
1137
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
73.6%
+33.6% vs TC avg
§102
16.6%
-23.4% vs TC avg
§112
8.9%
-31.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1102 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on March 19th, 2026 has been entered. Response to Arguments Applicant’s arguments with respect to the currently pending claims have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 91 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 91 recites the limitation "at least three of said openings" in line 2. There is insufficient antecedent basis for this limitation in the claim. For the purpose of examination, the claim has been interpreted to read: 91. (Currently Amended) The speculum of claim 83, wherein said petal assembly includes at least three petals and defines at three Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 83 and 92 are rejected under pre-AIA 35 U.S.C. 102(b) as being anticipated by Hamada (US 2008/0132764). Regarding claim 83, Hamada discloses a surgical access device, comprising a handle (181,figure 22) for gripping by a user; and a petal assembly (35, figure 1), connected to said handle (figure 25), including a plurality of petals (65, 69) for dilating an introitus of a patient (figures 22-24) and defining a viewing axis between said petals (central longitudinal axis between the petals) and extending between a proximate end of said petal assembly adjacent said handle and a distal end of said petal assembly remote from said handle (figures 11, 23-24), wherein said petal assembly is moveable between a dilated configuration (figures 11, 23-24) and a retracted configuration (figures 9, 22); and pinch guard structure (35, figure 1), disposed radially inside of said petal assembly (figures 3, 22), for inhibiting collapsing of walls of said introitus, radially between sides of adjacent petals, into an interior of said petal assembly when said petal assembly is in said dilated configuration (figures 23, 32); wherein, in said dilated configuration, said pinch guard structure extends into said petal assembly by at least a majority of a length of the petal assembly between said proximate end and said distal end (figures 11, 23-24, 32). Regarding claim 92, Hamada discloses portions of said petals of said petal assembly that overlap in said dilated configuration (portions overlap at 101 and 103 see figure 7). Allowable Subject Matter Claims 61 and 66-71 are allowed. Claims 84-90 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim 91 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATTHEW JAMES LAWSON whose telephone number is (571)270-7375. The examiner can normally be reached Mon - Fri 6:30-3:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anita Coupe can be reached at 571-270-3614. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MATTHEW J LAWSON/Primary Examiner, Art Unit 3619
Read full office action

Prosecution Timeline

Feb 06, 2024
Application Filed
Jun 26, 2025
Non-Final Rejection mailed — §102, §112
Dec 17, 2025
Response Filed
Jan 12, 2026
Final Rejection mailed — §102, §112
Mar 19, 2026
Request for Continued Examination
Mar 31, 2026
Response after Non-Final Action
Apr 21, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12672884
TOE IMPLANT ASSEMBLIES, KITS, SURGICAL METHODS, AND METHODS OF MANUFACTURING
2y 10m to grant Granted Jul 07, 2026
Patent 12667465
ADJUSTED STIFFNESS ORTHOPAEDIC IMPLANTS AND METHOD OF MANUFACTURE
2y 7m to grant Granted Jun 30, 2026
Patent 12661216
FEMORAL FIXATION
6y 9m to grant Granted Jun 23, 2026
Patent 12653693
EXPANDABLE IMPLANT ASSEMBLY
1y 8m to grant Granted Jun 16, 2026
Patent 12648781
OFFSET GUIDING DEVICE AND METHOD OF USE THEREOF
2y 11m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
99%
With Interview (+29.7%)
3y 4m (~11m remaining)
Median Time to Grant
High
PTA Risk
Based on 1102 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month